Himalaya Drug Company (HDC) today announced launch of two new drugs catering to women's healthcare segment, PTI reports from New Delhi. The company has introduced a drug for management of menopausal symptoms-Menosan and Reosto for combating osteoporosis, a release said. Priced at Rs 2 per tablet, Menosan has been marketed as an alternative to hormone replacement therapy without associated risks and adverse affects. Reosto eliminates risk of abnormally high calcium and Vitamin D levels in blood thereby preventing formation of calcium stones and slow bone loss along with incidence of fractures. The drug has been priced at Rs 1.5 per tablet and is available in dosage packs of 60 tablets.